Juno Therapeutics, Inc.

Company Details

Name:	Juno Therapeutics, Inc.
Jurisdiction:	Rhode Island
Entity type:	Foreign Corporation
Status:	Activ
Date of Organization in Rhode Island:	02 Jan 2018 (7 years ago)
Identification Number:	001680071
Place of Formation:	DELAWARE
Principal Address:	400 DEXTER AVENUE NORTH SUITE 1200, SEATTLE, WA, 98109, USA
Purpose:	ACCELERATING MEDICINE ON A GLOBAL SCALE
NAICS:	325412 - Pharmaceutical Preparation Manufacturing

Agent

Name	Role	Address
CT CORPORATION SYSTEM	Agent	450 VETERANS MEMORIAL PARKWAY SUITE 7A, EAST PROVIDENCE, RI, 02914, USA

PRESIDENT

Name	Role	Address
SOPHIA PARK	PRESIDENT	400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE, WA 98109 USA

DIRECTOR, VICE PRESIDENT, SECRETARY

Name	Role	Address
KIMBERLY M. JABLONSKI	DIRECTOR, VICE PRESIDENT, SECRETARY	400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE, WA 98109 USA

DIRECTOR, VICE PRESIDENT, TREASURER

Name	Role	Address
SANDRA RAMOS-ALVES	DIRECTOR, VICE PRESIDENT, TREASURER	400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE, WA 98109 USA

VICE PRESIDENT

Name	Role	Address
SCOTT MATARESE	VICE PRESIDENT	400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE, WA 98109 USA

ASSISTANT SECRETARY

Name	Role	Address
ELISABETH S. BRADLEY	ASSISTANT SECRETARY	400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE, WA 98109 USA
LISA A. ATKINS	ASSISTANT SECRETARY	400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE, WA 98109 USA

DIRECTOR

Name	Role	Address
SOPHIA PARK	DIRECTOR	400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE, WA 98109 USA

Filings

Number	Name	File Date
202451932840	Annual Report	2024-04-22
202334012500	Annual Report	2023-04-26
202225102060	Statement of Change of Registered/Resident Agent	2022-12-08
202216435700	Annual Report	2022-04-30
202193206760	Annual Report	2021-02-27
202033127910	Annual Report	2020-01-27
201986377690	Annual Report	2019-02-11
201855543780	Application for Certificate of Authority	2018-01-02

Date of last update: 27 Oct 2024

Sources: Rhode Island Department of State